Preview

Experimental and Clinical Gastroenterology

Advanced search

Epidemiology of pancreatic cancer

https://doi.org/10.31146/1682-8658-ecg-211-3-17-21

Abstract

At present, pancreatic cancer morbidity continues to grow at an accelerated rate worldwide. At the same time the five-year survival rate of patients with pancreatic cancer remains low, occupying a significant position in the mortality structure. This is mainly due to late diagnosis, as well as to the increasing proportion of the elderly population. Factors influencing the prognosis include age, sex, blood group, family history and genetic predisposition, diabetes, smoking, alcohol, chronic pancreatitis, and obesity. Objective: to present up-to-date data on pancreatic cancer epidemiology in the world, Russian Federation and Omsk region. Materials and methods: the article analyzes the data of morbidity, mortality and five-year survival rate of patients with pancreatic cancer for the years 2020-2021. Results: the growth of morbidity and persistent low survival rates emphasize the necessity of determining methods of screening patients with high risk of pancreatic cancer, developing methods of early detection and improving both surgical and drug treatment of these patients, as well as prophylaxis.

About the Authors

M. V. Naboka
Omsk State Medical University
Russian Federation


A. V. Otmakhova
Omsk State Medical University
Russian Federation


P. V. Bogdanchikova
Omsk State Medical University
Russian Federation


D. M. Viushkov
Omsk State Medical University
Russian Federation


References

1. Cancer Today: Data visualization tool for exploring the global cancer burden in 2020 [Internet].International Agency for Research on Cancer, Lyon France. 2020. Available at: http: gco.iarc.fr/today/home. Access 2021 June 26

2. Alison P. K. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021; 18(7): 493-502. doi: 10.1038/s41575-021-00457-x.

3. Jonathan D.M, Rishi S., Prof Juan W. V., Rachna T. S. Pancreatic cancer. The Lancet. 2020; 10242(395): 2008-2020. doi: 10.1016/S0140-6736(20)30974-0.

4. Kaprina A. D., Starinskogo V. V., Shahzadovoi A. O. [The state of oncological care for the population of Russia in 2021]. Moscow. MNIOI im. P. A. Gercena - filial FGBU “NMIC radiologii” Minzdrava Rossii. 2022:239. (In Russ). ISBN 978-5-85502-210-0.@@ Каприна А. Д., Старинского В. В., Шахзадовой А. О. Состояние онкологической помощи населению России в 2021 году. М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2022: 239. ISBN 978-5-85502-210-0.

5. Boiko V. P. [Order of the government of the Omsk region on the regional program “Fight against cancer” for 2019-2024]. Omsk. 2019, pp. 7-9. (In Russ).@@ Бойко В. П. Распоряжение правительства Омской области о региональной программе «Борьба с онкологическими заболеваниями» на 2019-2024 годы. - Омск, 2019:7-9.

6. McGuigan A., Kelly P., Turkington R. C., Jones C., Coleman H. G., McCain R. C. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846-4861. doi: 10.3748/wjg.v24.i43.4846.

7. Ilic M., Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694-9705. doi: 10.3748/wjg.v22.i44.9694.

8. Bosetti C., Lucenteforte E., Silverman D. T., Petersen G., Bracci P. M., Ji B. T., Negri E., Li D., Risch H. A., Olson S. H. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol. 2012;23:1880-1888. doi: 10.1093/annonc/mdr541.


Review

For citations:


Naboka M.V., Otmakhova A.V., Bogdanchikova P.V., Viushkov D.M. Epidemiology of pancreatic cancer. Experimental and Clinical Gastroenterology. 2023;(3):17-21. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-211-3-17-21

Views: 478


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)